Please see Important Safety Information, including Boxed Warning, in the pinned post. See full Prescribing Information at http://bit.ly/IbsrelaPI.
This page is intended for US healthcare professionals only.
To report an adverse event or product claim, please call the FDA at 1-800-FDA-1088. You may also report side effects to www.fda.gov/medwatch.
© Ardelyx, Inc. 2024. All rights reserved.
Ardelyx and IBSRELA are registered trademarks and ArdelyxAssist is a trademark of Ardelyx, Inc.
US-IBS-0365 05/24
The products described on this site may have different product labeling in countries outside the United States.
Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://ibsrela-hcp.com
- Keywords
- Alpental Capital.
Ibsrela® (Tenapanor) Questions
Ibsrela® (Tenapanor)'s website is https://ibsrela-hcp.com
Ibsrela® (Tenapanor)'s LinkedIn profile is https://www.linkedin.com/company/ibsrela
Ibsrela® (Tenapanor)'s industry is
Pharmaceutical Manufacturing
Ibsrela® (Tenapanor)'s top competitors are
Ardelyx, Inc.,
University Housing Solutions,
The Register,
Surge Energy America,
Alpental Capital,
Dpanalytics Llc,
Vaccinogen,
Neosensory, Inc.,
Coyote Ventures,
Munson Healthcare.
Ibsrela® (Tenapanor)'s categories are Pharmaceutical Manufacturing
